“Trump gewinnt 30 Milliarden mit Intel” - Novo schlägt Lilly, NVIDIA > 5.000 & Brasilien
The episode covers major market news including Intel's dramatic 24% stock surge driven by CPU demand and improved chip yields, Novo Nordisk outperforming Eli Lilly in the weight-loss pill market, and an analysis of why Latin American markets — particularly Brazil — are outperforming global indices due to high oil prices and Petrobras dynamics.
Summary
The episode opens with a discussion of failed US-Iran peace negotiations, which were canceled over the weekend before markets could react. Defense stocks like Rheinmetall lost ground on Friday, partly due to peace hopes and partly because Trump fired the head of the US Navy over concerns about budget and timeline overruns in fleet expansion programs.
Procter & Gamble reported solid quarterly results despite the oil price headwind costing the company roughly $1 billion annually. Notably, product sales volume grew by 2% for the first time in a year — a milestone the host highlights as more meaningful than price-driven growth. The company also shared that influencer marketing campaigns for brands like Pantene tripled reach while cutting marketing budgets by 20%. By contrast, German forklift and logistics company Jungheinrich saw its share drop 15% after operating profit halved, driven by a factory strike, Chinese competition, and internal ownership conflicts.
In the pharmaceutical space, Novo Nordisk reclaimed momentum over Eli Lilly in the weight-loss pill market. Novo's newly approved oral pill saw 18,000 prescriptions in its second week versus Lilly's 3,700, sending Novo's stock up 7% and Lilly's down 4%.
Nuclear startup X-Energy went public and immediately surged 30%, reaching a $10 billion market cap despite only $90 million in revenue, driven by expectations of small modular nuclear reactors entering production in the early 2030s and existing contracts with Amazon.
In AI investment news, Alphabet announced a $10 billion immediate and $30 billion multi-year investment in Anthropic, with computing access being highlighted as even more valuable than the capital. European AI company Aleph Alpha was acquired by Canadian firm Cohere, with Schwarz Group taking a €500 million stake — described as modest relative to US-scale AI deals but significant given Aleph Alpha's recent struggles. Meta also struck a multi-billion dollar multi-year CPU deal with Amazon, signaling rising demand for CPUs alongside GPUs.
The central tech story is Intel's 24% single-day stock surge — its strongest since 1987 — driven by massively exceeding analyst expectations on sales and profits. CPU demand is soaring, and Intel holds a strong market position there unlike in GPUs. Key revelations from the analyst call include Intel reaching internal yield targets ahead of schedule and now being able to sell chips previously discarded or reserved for simpler applications, because customers want anything they can get. The host frames this as a fundamental shift: two years ago Intel needed to match TSMC's quality; today solid delivery is enough because TSMC cannot serve all demand. Nvidia also hit a new all-time high above $5 trillion in market cap on the same day.
The episode closes with an analysis of Brazil and Latin America. The MSCI Latin America index is up over 20% year-to-date while European and US indices are roughly flat, largely because most major Latin American economies are net oil and gas exporters. Brazil's state oil company Petrobras raised jet fuel prices by 55% but froze domestic gasoline and diesel prices for political reasons — President Lula is seeking a fourth term and is polling behind challenger Flavio Bolsonaro for the first time. This political pricing strategy has cost Petrobras an estimated $2-3 billion since the start of the Iran conflict, yet the stock is still up over 60% this year and yields a 6% dividend. Investment options discussed include the iShares MSCI Brazil ETF (heavily concentrated in Petrobras and Vale, making it essentially a commodities bet) and Itaú Unibanco, Brazil's largest private bank, trading at a P/E of 10 with a 7% dividend yield.
Key Insights
- The host argues that Intel's most significant competitive shift is not matching TSMC's quality, but simply being able to deliver at all — because TSMC cannot serve all existing demand, solid execution is now sufficient for Intel to win business.
- The host highlights that Procter & Gamble's 2% volume growth is more meaningful to the market than price-driven growth, framing volume expansion as a more sustainable signal of company health.
- The host explains that Petrobras has deliberately frozen domestic fuel prices despite rising global oil prices for political reasons — President Lula is trailing in polls ahead of elections and is protecting voter purchasing power, at a cost the host estimates at $2-3 billion since the Iran conflict began.
- The host notes that Novo Nordisk's newly approved oral weight-loss pill received 18,000 prescriptions in its second week versus Eli Lilly's 3,700 for its competing product, suggesting Novo is maintaining its lead in the oral GLP-1 segment despite Lilly's aggressive expansion.
- The host argues that for Intel to justify its current valuation, two things must be believed: first, that Intel can improve its gross margins from 40% toward the 50-60% range of competitors like TSMC and AMD, and second, that the current exceptionally high chip demand cycle will persist long enough to drive meaningful revenue growth.
Topics
Full transcript available for MurmurCast members
Sign Up to Access